Stock EURI B EUROPEAN INSTITUTE OF SCIENCE AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials European Institute of Science AB

Equities

EURI B

SE0020357457

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
2.98 SEK +2.76% Intraday chart for European Institute of Science AB +14.62% -76.50%
Jul. 10 European Institute of Science AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
Apr. 30 European Institute of Science AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2.476 3.63 7.204 8.42 14.93 4.402
Enterprise Value (EV) 1 1.488 3.496 5.793 5.42 10.64 2.852
P/E ratio -0.6 x -1.12 x -2.26 x -2.82 x -1.48 x -1.62 x
Yield - - - - - -
Capitalization / Revenue 6.21 x 9.84 x 13.8 x 15.7 x 28.2 x 7.33 x
EV / Revenue 3.73 x 9.48 x 11.1 x 10.1 x 20.1 x 4.75 x
EV / EBITDA -0.48 x -1.21 x -2.41 x -2.15 x -3.91 x -
EV / FCF -0.79 x -1.34 x -7.83 x -3.43 x -6.5 x -1.63 x
FCF Yield -126% -74.5% -12.8% -29.1% -15.4% -61.3%
Price to Book 1.7 x 2.75 x 3.93 x 2.46 x 3.22 x 2.29 x
Nbr of stocks (in thousands) 17.9 21.4 43.4 86.8 347 347
Reference price 2 138.0 170.0 166.0 97.00 43.00 12.68
Announcement Date 4/26/19 2/28/20 5/11/21 3/4/22 5/10/23 5/15/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.3989 0.3688 0.5233 0.5356 0.5286 0.6009
EBITDA 1 -3.105 -2.88 -2.399 -2.522 -2.724 -
EBIT 1 -3.106 -2.885 -2.404 -2.527 -2.728 -2.771
Operating Margin -778.55% -782.16% -459.5% -471.93% -516.01% -461.21%
Earnings before Tax (EBT) 1 -3.107 -2.889 -2.405 -2.529 -2.728 -2.717
Net income 1 -3.107 -2.889 -2.405 -2.529 -2.728 -2.717
Net margin -778.86% -783.22% -459.57% -472.24% -516.06% -452.22%
EPS 2 -230.9 -151.8 -73.54 -34.36 -29.04 -7.826
Free Cash Flow 1 -1.877 -2.605 -0.7403 -1.579 -1.638 -1.749
FCF margin -470.62% -706.39% -141.46% -294.9% -309.81% -291.15%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/26/19 2/28/20 5/11/21 3/4/22 5/10/23 5/15/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.99 0.13 1.41 3 4.29 1.55
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1.88 -2.61 -0.74 -1.58 -1.64 -1.75
ROE (net income / shareholders' equity) -159% -215% -152% -96.2% -67.7% -82.8%
ROA (Net income/ Total Assets) -87.8% -104% -76.9% -55.2% -40.2% -49.9%
Assets 1 3.537 2.765 3.128 4.582 6.794 5.449
Book Value Per Share 2 81.30 61.80 42.30 39.40 13.40 5.540
Cash Flow per Share 2 58.50 6.270 32.50 34.60 12.30 4.470
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 4/26/19 2/28/20 5/11/21 3/4/22 5/10/23 5/15/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
EUROPEAN INSTITUTE OF SCIENCE AB Stock European Institute of Science AB
-76.50% 152K
MODERNA, INC. Stock Moderna, Inc.
+25.83% 47.96B
LONZA GROUP AG Stock Lonza Group AG
+45.38% 41.47B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.69% 42.45B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+30.52% 31.6B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+22.30% 28.63B
CELLTRION, INC. Stock Celltrion, Inc.
-6.35% 28.03B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+49.25% 14.56B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+49.18% 14.14B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.45% 12.58B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. EURI B Stock
  4. Financials European Institute of Science AB